'hylloquinone (vitamin K) is essential to prevent hemortiagic diseases in newborns. We were interested in etermining the concentration of phylloquinone in human nilk and in elucidating the factors that influence that oncentration. Human milk contains lipid constituents ncapsulated with phylloquinone in the fat globules. To Iiminate the lipids, we combined sonication and an )nzymatlc treatment with lipase to prevent degradation by irastic hydrolysis. Despite the low phylloquinoneconcenrations and the procedure's complexity (lipase treatment, wo HPLC steps, and an on-line thermoinduced postcolimn reduction followed by fluorescence detection), withn-day and day-to-day CVs of 5.2% and 5.8% were )btained (n = 8, = 1.86 ig/L, and n = 7, = 1.74 pg/L, espectively 
The results of their bioassay in the early 1940s for )hylloqunlone in human milk suggested to Dam et a!. 1) that an insufficient supply of phylloquinone from naternal milk can lead to the classical hemorrhagic lisease of newborns. Other studies supported this hyothesis by demonstrating that the incidence of this yndrome is much higher in infants who are exclusively reast-fed (2, 3) . This observation was even more proounced for babies who developed a late-onset form Human milk contains a large amount of lipids in fat lobules that are encased in protein-phospholipid memanes (8 
Milk Sampling
The phylloquinone concentration and the lipid composition of breast milk during the course of lactation were evaluated by analyzing milk samples obtained by manual expression during a single feeding, but at different days of lactation and at all nursing times throughout the day, ad libitum. In addition, care was taken not to collect milk at the very beginning or end of the feeding. Samples (8 mL) were obtained starting from the day of birth up to 82 days postpartum.
Milk samples were collected away from direct sunlight and were frozen immediately at -18 #{176}C until analysis.
Enzymatic Hydrolysis and Extraction
Before the pipetting, milk samples were kept for 30 mm at 25 #{176}C to ensure homogeneity. To a 500-ML aliquot of human milk we added 2.7 ng of the internal standard (50 L of an ethanolic solution). We also added 10 To the reaction mixture we added 4 mL of ethanol, 2 mL of water, and 200 pL of NH4OH (50 g/L) before we extracted the phylloquinone with 7.5 mL of n-hexane by vortex-mixing for 2 miii.
Chromatography
Purification of the crude extract was performed on the adsorption column eluted with n-hexane and diisopropyl ether (98.5:1.5, by vol) at a flow rate of 0.85 mL/min. We collected the fraction of the column effluent that contained both the phylloquinone and the internal standard, and we evaporated this to dryness. Figures IA and 18 and in Figures 2A-F. In addition, the effect of lipase treatment and sonication can be followed by the disappearance of interfering peaks in these chromatograrns.
The effect of lipase treatment can be seen in the resulted in a high peak that eluted exactly in the collection window. In Figure lB (sonication and the addition of 4 mg of lipase) this peak is much smaller. Addition of more lipase (6 mg) did not result in a total removal of the peak. The effect of lipase treatment was even more clear in the chromatograms obtained on the reversed-phase column combined with the fluorescence detection (Figures 2A-F) . A too-small amount of lipase added or the omission of the sonication always resulted in an interfering peak eluting close to the phylloquunone peak. Only the combination of sonication and the addition of 4 mg of crude lipase resulted in a complete elimination of the interfering peak and allowed quantitative measurement.
The lipase treatment also drastically prolonged column life because fewer lipid constituents are injected under these conditions. In view of the complexity both of the matrix and of th analytical procedure (enzymatic treatment, two chro matographic systems, and postcolumn reaction), linear ity, within-day reproducibility, and day-to-day repro ducibility are quite acceptable. The 62.5% recovers seems low, but incomplete transfer of the n-hexan layer (maximum 7.0 of 7.5 mL) and the partial injectior of the redissolved residue (100/120 ILL) already repre sent a loss of >20%.
Compound Stabilify
There was no remarkable difference between thi degradation with and without contact with NH4OH even over a period of 30 mm.
Phylloquinone and Lipid Constituents
The results of the analyses of phylloquinone and o the lipids in the human milk samples are presented is Table 1 On the other hand, a positive correlation was observed between the phylloquinone concentration and the phospholipid (r = 0.5578) and cholesterol content (r = 0.6020) of the milk ( Figure  4B ). No correlation was observed between phylloquinone and triglyceride content (r = 0.1489).
In a separate experiment we obtained from nine mothers two or four milk samples on the same day. For this study, it was important that the sampling method was exactly the same during that day (11). Some results indicate a large variation in phylloquinone concentration within one day (Table 2) , corresponding with similar observations (24) for cholesterol and phospholipids. The concentration often was higher in the evening sample. This can be correlated with the appearance in the milk of the phylloquinone absorbed from the noon meal. In addition to the time of sampling after a meal (10), the composition of the meal itself is an important influence on the concentration of phylloquinone in hu- reported for cow milk (10). Consequently, for breast-fed babies the input of phylloquinone is clearly lower than it is for babies who are fed cow milk. Disease-related causes or effects were not considered in our study.
